Skip to content

Analysis of Weight Management Effectiveness and Mechanism Research in Obese PopulationsEffectiveness and Mechanisms of Weight Management Interventions in Obese Populations: An Analytical Study APA

Analysis of Weight Management Effectiveness and Mechanism Research in Obese PopulationsEffectiveness and Mechanisms of Weight Management Interventions in Obese Populations: An Analytical Study APA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000556
Enrollment
Unknown
Registered
2025-03-20
Start date
2025-03-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight/Obesity

Interventions

Massage device group:Massage device combined with lifestyle modifications
lifestyle group:lifestyle modifications
orlistat group:orlistat combined with lifestyle modifications

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria are as follows: 1) BMI (Body Mass Index) = 24 kg/m²; 2) Willing to utilize the massage device orlistat and lifestyle modifications for weight management; 3) Willing to receive guidance on lifestyle adjustments from physicians or researchers; 4) Capable of providing informed consent; 5) Age: 18-64 years old.

Exclusion criteria

Exclusion criteria: The exclusion criteria are as follows: 1) Weight fluctuation = 5 kg in the past three months; 2) Previous weight loss of = 5% achieved through 3-6 months of dietary control and/or exercise therapy alone; 3) Undergone treatments affecting body weight (including sedatives antidepressants steroids and hormonal medications) or participated in other weight loss programs (e.g. dietary restrictions physical training) in the past three months; 4) Planning to relocate from the area within one year; 5) History of weight loss surgery or planning to undergo weight loss surgery within one year; 6) History of suicidal behavior or diagnosed with eating disorders (binge eating disorder anorexia nervosa); 7) History of psychiatric hospitalization or substance abuse; 8) Active cancer; 9) Severe arrhythmia or cardiomyopathy severe congestive heart failure stroke or heart attack within the past six months; 10) Chronic inflammatory diseases including but not limited to severe arthritis lupus or inflammatory bowel disease (i.e. Crohn's disease or ulcerative colitis); 11) Life-threatening illnesses or conditions that may be exacerbated by exercise or weight loss; 12) Secondary obesity caused by hypothalamic disorders anterior pituitary hypofunction etc.; 13) Pregnant women; 14) Allergic to materials such as silicone polycarbonate stainless steel etc.

Design outcomes

Primary

MeasureTime frame
weight;

Secondary

MeasureTime frame
fasting insulin;fasting C-peptide;IWQOL-Lite (Impact of Weight on Quality of Life-Lite) questionnaire;height;body mass index(BMI);waist circumference;glycated hemoglobin (HbA1c);lipid profile (four items);hip circumference;blood pressure;fasting blood glucose;gut microbiota collection;body composition analysis (body fat percentage);waist-to-hip ratio;traditional Chinese medicine (TCM) constitution assessment;C-reactive protein;

Countries

China

Contacts

Public ContactLIYINGSHUAI

Beijing University of Chinese Medicine

liyingshuai2013@163.com13681410020

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026